Pharmacy Usual Items - Australia

  • Australia
  • Revenue in the Pharmacy Usual Items market is projected to reach US$5.14bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 5.51%, resulting in a market volume of US$6.37bn by 2028.
  • In global comparison, most revenue will be generated in China (US$48,050.00m in 2024).
  • In relation to total population figures, per person revenues of US$192.50 are generated in 2024.

Key regions: Canada, United States, France, South Korea, India

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Pharmacy Usual Items market in Australia has been experiencing significant growth in recent years.

Customer preferences:
Customers in Australia have shown a strong preference for purchasing pharmacy usual items, such as over-the-counter medications, personal care products, and health supplements. This can be attributed to several factors. Firstly, there is a growing awareness and emphasis on self-care and preventive healthcare among Australians. As a result, they are more inclined to proactively manage their health and wellbeing by purchasing these items. Additionally, the convenience and accessibility offered by pharmacies in Australia have also contributed to the increasing demand for pharmacy usual items. Many pharmacies operate extended hours and offer online shopping options, making it easier for customers to access these products.

Trends in the market:
One of the key trends in the Pharmacy Usual Items market in Australia is the rise of natural and organic products. Consumers are becoming more conscious about the ingredients used in the products they use, and are opting for natural alternatives. This trend is particularly evident in the personal care and health supplement segments, where there has been a surge in demand for products that are free from artificial additives and chemicals. This shift towards natural and organic products is driven by factors such as increasing health consciousness, environmental concerns, and a desire for sustainable and ethical choices. Another trend in the market is the growing popularity of online shopping for pharmacy usual items. With the advancement of technology and the increasing prevalence of e-commerce platforms, more and more Australians are choosing to purchase these items online. This can be attributed to the convenience, wider product selection, and competitive pricing offered by online retailers. However, brick-and-mortar pharmacies still play a significant role in the market, as customers value the expertise and personalized advice provided by pharmacists.

Local special circumstances:
Australia has a unique regulatory environment for pharmacy usual items. The Therapeutic Goods Administration (TGA) is responsible for regulating and ensuring the safety, quality, and efficacy of these products. This stringent regulatory framework provides assurance to customers and contributes to their trust in pharmacy usual items. Additionally, the Pharmaceutical Benefits Scheme (PBS) in Australia subsidizes the cost of certain prescription medications, making them more affordable for consumers. This has a positive impact on the overall demand for pharmacy usual items, as customers are more likely to visit pharmacies for their healthcare needs.

Underlying macroeconomic factors:
The growth of the Pharmacy Usual Items market in Australia can be attributed to several underlying macroeconomic factors. Firstly, Australia has a growing and aging population, which is driving the demand for healthcare products and services. As the population ages, there is an increased need for medications, personal care products, and health supplements to support healthy aging and manage age-related conditions. Additionally, Australia has a strong healthcare system and a high level of healthcare expenditure, which further supports the growth of the Pharmacy Usual Items market. In conclusion, the Pharmacy Usual Items market in Australia is experiencing significant growth due to customer preferences for self-care and preventive healthcare, the rise of natural and organic products, the increasing popularity of online shopping, unique local regulations, and underlying macroeconomic factors such as population growth and healthcare expenditure. This trend is expected to continue in the coming years as Australians prioritize their health and wellbeing.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)